Unknown

Dataset Information

0

[WUSTL] [PDX] [WUSTL-WHIM3] HER2-Positive Breast Carcinoma

ABSTRACT:

SUBMITTER:  

PROVIDER: S-CMO6589 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown [WUSTL] [PDX] [WUSTL-WHIM8] HER2-Positive Breast Carcinoma
| S-CMO6443 | biostudies-other
Unknown [WUSTL] [PDX] [WUSTL-WHIM11] HER2-Positive Breast Carcinoma
| S-CMO6641 | biostudies-other
Unknown [WUSTL] [PDX] [WUSTL-WHIM22] HER2-Positive Breast Carcinoma
| S-CMO6539 | biostudies-other
Unknown [WUSTL] [PDX] [WUSTL-WHIM35] HER2-Positive Breast Carcinoma
| S-CMO6615 | biostudies-other
Unknown THER-12. PRECLINICAL EVALUATION OF NERATINIB PLUS T-DM1 IN ORTHOTOPIC PDX MODELS OF HER2-POSITIVE BREAST CANCER BRAIN METASTASES
| S-EPMC7213268 | biostudies-literature
Unknown HER2 positive primary breast squamous cell carcinoma with good prognosis: a case report.
| S-EPMC11760515 | biostudies-literature
Unknown Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma.
| S-EPMC4134494 | biostudies-literature
Unknown Neoadjuvant therapy for HER2-positive acantholytic squamous cell breast carcinoma: a case report.
| S-EPMC10566270 | biostudies-literature
Unknown rBC2LCN lectin as a potential probe of early-stage HER2-positive breast carcinoma.
| S-EPMC7262912 | biostudies-literature
Unknown Immunotherapies against HER2-Positive Breast Cancer.
| S-EPMC9954045 | biostudies-literature